Clifford Chance, Wachtell Help Pfizer To Cut Haleon Stake
Pharmaceutical titan Pfizer has reduced its stake in Haleon PLC, the British healthcare giant, to 7.3% by selling shares worth £2.5 billion ($3 billion), a bookrunner for the sale said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article